NEPHROS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | $824.0K | $4.7M | $4.2M |
| FY2020 | $593.0K | $12.5M | $8.2M |
| FY2021 | $343.0K | $11.7M | $7.0M |
| FY2022 | $71.0K | $5.6M | $3.6M |
| FY2023 | — | $8.4M | $4.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | $824.0K | $4.7M | $4.2M |
| FY2020 | $593.0K | $12.5M | $8.2M |
| FY2021 | $343.0K | $11.7M | $7.0M |
| FY2022 | $71.0K | $5.6M | $3.6M |
| FY2023 | — | $8.4M | $4.3M |